Leah E. Mechanic

Leah E. Mechanic

Auto-generated profile, based on publicly available information

Leah E. Mechanic

National Cancer Institute 1 Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences National Institutes of Health, Rockville, Maryland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2017 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
KMKimberly McAllister
Kimberly McAllister
LMLeah E Mechanic
Leah E Mechanic
CAChristopher Amos
Christopher Amos
HAHugues Aschard
Hugues Aschard
IBIan A Blair
Ian A Blair
JWJohn S Witte
John S Witte
Recently, many new approaches, study designs, and statistical and analytical methods have emerged for studying gene-environment interactions (G×Es) in large-scale studies of human populations. There are opportunities in this field, particularly with respect to the incorporation of -omics and next-generation sequencing data and continual improvement in measures of environmental exposures implicated in complex disease outcomes. In a workshop called “Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases,” held October 17–18, 2014, by the National Institute of Environmental Health Sciences and the National Cancer Institute in conjunction with the annual American Society of Human Genetics meeting, participants explored new approaches and tools that have been developed in recent years for G×E discovery. This paper highlights current and critical issues and themes in G×E research that need additional consideration, including the improved data analytical methods, environmental exposure assessment, and incorporation of functional data and annotations.

6 January 2006 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
LMLeah E. Mechanic
Leah E. Mechanic
RMRobert C. Millikan
Robert C. Millikan
JPJon Player
Jon Player
ACAllan René de Cotret
Allan René de Cotret
SWScott Winkel
Scott Winkel
TKTemitope Keku
Temitope Keku
Polymorphisms exist in several genes involved in nucleotide excision repair (NER), the principal pathway for removal of smoking-induced DNA damage. An epidemiologic study was conducted to determine whether these polymorphisms modify the association between smoking and breast cancer. DNA samples and exposure histories were analyzed as part of a large population-based case–control study of breast cancer in North Carolina. The study population included 2311 cases (894 African Americans, 1417 whites) and 2022 controls (788 African Americans, 1234 whites). Odds ratios (ORs) were calculated for breast cancer and smoking, and for breast cancer and nine non-synonymous coding polymorphisms in six NER genes ( XPD codons 312 and 751, RAD23B codon 249, XPG codon 1104, XPC codon 939, XPF codons 415 and 662, and ERCC6 codons 1213 and 1230). Modification of ORs for smoking by single and combined NER genotypes was investigated. In this study population, smoking was more strongly associated with breast cancer in African American women compared with white women. Among African American women, the association of breast cancer and smoking was strongest among women with specific combinations of NER genotypes. Evidence for multiplicative interaction was found between combined NER genotypes and smoking dose (likelihood ratio test P = 0.06), duration ( P = 0.09), time since cessation ( P = 0.02), age at initiation ( P = 0.04) and former smoking ( P = 0.03). No interactions were observed in white women. Therefore, polymorphisms in NER genes may modify the relationship between breast cancer and smoking. These results are consistent with previous evidence of exposure-specific p53 mutations in breast tumors from current and former smokers, suggesting that smoking may play a role in breast cancer etiology.

7 April 2016 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
NSNaoko I. Simonds
Naoko I. Simonds
AGArmen A. Ghazarian
Armen A. Ghazarian
CPCamilla B. Pimentel
Camilla B. Pimentel
SSSheri D. Schully
Sheri D. Schully
GEGary L. Ellison
Gary L. Ellison
LMLeah E. Mechanic
Leah E. Mechanic

6 December 2011 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
LMLeah E. Mechanic
Leah E. Mechanic
HCHuann‐Sheng Chen
Huann‐Sheng Chen
CAChristopher I. Amos
Christopher I. Amos
NCNilanjan Chatterjee
Nilanjan Chatterjee
NCNancy J. Cox
Nancy J. Cox
EGElizabeth M. Gillanders
Elizabeth M. Gillanders

6 March 2008 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
LMLeah E Mechanic
Leah E Mechanic
BLBrian T Luke
Brian T Luke
JGJulie Goodman
Julie Goodman
SCStephen J. Chanock
Stephen J. Chanock
CHCurtis C. Harris
Curtis C. Harris
Background: The risk of common diseases is likely determined by the complex interplay between environmental and genetic factors, including single nucleotide polymorphisms (SNPs). Traditional methods of data analysis are poorly suited for detecting complex interactions due to sparseness of data in high dimensions, which often occurs when data are available for a large number of SNPs for a relatively small number of samples. Validation of associations observed using multiple methods should be implemented to minimize likelihood of false-positive associations. Moreover, high-throughput genotyping methods allow investigators to genotype thousands of SNPs at one time. Investigating associations for each individual SNP or interactions between SNPs using traditional approaches is inefficient and prone to false positives. Results: We developed the Polymorphism Interaction Analysis tool (PIA version 2.0) to include different approaches for ranking and scoring SNP combinations, to account for imbalances between case and control ratios, stratify on particular factors, and examine associations of user-defined pathways (based on SNP or gene) with case status. PIA v. 2.0 detected 2-SNP interactions as the highest ranking model 77% of the time, using simulated data sets of genetic models of interaction (minor allele frequency = 0.2; heritability = 0.01; N = 1600) generated previously [Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, Moore JH: A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol 2007, 31:306–315.]. Interacting SNPs were detected in both balanced (20 SNPs) and imbalanced data (case:control 1:2 and 1:4, 10 SNPs) in the context of non-interacting SNPs. Conclusion: PIA v. 2.0 is a useful tool for exploring gene*gene or gene*environment interactions and identifying a small number of putative associations which may be investigated further using other statistical methods and in replication study populations.

22 September 2022 in Genetics in Medicine
Verified
Journal Article
Open access
JTJessica C. Tiner
Jessica C. Tiner
LMLeah E. Mechanic
Leah E. Mechanic
LGLisa Gallicchio
Lisa Gallicchio
EGElizabeth M. Gillanders
Elizabeth M. Gillanders
KHKathy J. Helzlsouer
Kathy J. Helzlsouer
Genetic testing is a tool used in a variety of settings for medical and nonhealth related purposes. The goal of this analysis was to better understand the awareness and use of genetic testing in the United States. Data from the 2020 Health Information National Trends Survey 5 cycle 4 were used to assess the awareness and use of genetic testing by demographic characteristics, personal cancer history, and family cancer history. Overall, 75% of participants were aware of genetic testing and 19% of participants had genetic testing. Ancestry testing was the most common type of testing that the participants were aware of and had received. Non-Hispanic Asian, Non-Hispanic Black, and Hispanic respondents and participants with incomes less than $20,000 were less likely to be aware of and have received any type of genetic testing than the Non-Hispanic White participants and participants with higher income, respectively. Participants with a family history of cancer were more likely to be aware of cancer genetic testing than those without, and participants with a personal history of cancer were more likely to have had cancer genetic testing. It appears awareness of genetic testing is increasing in the United States, and differences in awareness persist by race/ethnicity and income.